Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease (Q74428168)
scientific article published on 01 July 2002
Language:
(P31) (Q13442814)
(P50) (Q63987185)
(Q110797660)
(Q85544110)
(Q90053593)
(P304) 23-28
(P433) 1
(P478) 30
(P577) Monday, July 1, 2002
(P921) (Q65592366)
(Q5731687)
(P1433) (Q4941523)
(P1476) "Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease" (language: en)
(P2093) C Sickles
P A Mangan
S J Schuster
D E Tsai
S Nasta
A M Gewirtz
(P2860) (Q33741270)
(Q33751243)
(Q73911932)
(Q28204295)
(Q33883225)
(Q33785643)
(Q33948594)
(Q42282952)
(Q42549090)
(Q42263116)
(Q57636835)
(Q40721259)
(Q28207989)
(Q77813043)
(Q73761102)
(Q59405894)
(Q72787968)
(Q72768944)
(Q60305554)
(Q34320203)
(Q33333561)
other details
description scientific article published on 01 July 2002

External Links